What happens next depends on symptoms, age, history, how high the number is and what the rest of the workup shows. A clinician decides whether the result calls for a repeat sample, stool infection testing, imaging or a direct look inside the bowel.
Calprotectin is a calcium and zinc binding protein stored inside neutrophils, the first-response white blood cells that arrive wherever tissue is irritated or injured. It makes up a large share of the protein held in the fluid part of those cells, so wherever neutrophils gather in large numbers, calprotectin follows.
In the gut, the mechanism is simple to picture. When the intestinal lining is inflamed, neutrophils leave the bloodstream, squeeze between the cells of the mucosa and migrate into the bowel lumen. As they activate, degranulate and break down, their contents spill into whatever is passing through. Calprotectin travels down the intestine with that material and leaves the body in stool, where a laboratory can measure it.
Two properties make this useful as a test. First, the protein is unusually tough. It resists breakdown by gut bacteria and digestive enzymes, so it is still measurable by the time a sample reaches the lab. Research suggests the protein stays stable in stool for several days at room temperature, which is part of why a posted sample can still give a workable result 1. Second, the amount is graded rather than simply present or absent. More neutrophil traffic into the gut generally means a higher number, so the test behaves like a dial rather than a switch.
Calprotectin also has a job of its own. By binding calcium and zinc it limits the metals available to microbes, giving it antimicrobial activity in the gut environment 1. That biology is why the marker tracks neutrophil activity so closely, and why it is specific to the gut in a way that a blood test cannot be. A stool sample only reflects what is happening between the mouth and the rectum.
A raised number tells you that more neutrophils than usual have crossed into the gut lining and lumen, which is the signature of inflammation of the bowel mucosa. It does not tell you where along the gut that inflammation sits, how long it has been there, or what started it.
That distinction matters because it sets realistic expectations. The test is a quantitative inflammation signal from the gut, not a disease label. The same raised value can come from an inflammatory bowel condition, an infection that has irritated the bowel wall, or another process that draws neutrophils into the mucosa.
Where the test earns its place is in sorting symptoms that look identical from the outside. Abdominal pain, urgency, loose stools and bloating can come from an inflamed bowel or from a gut that is sensitive and poorly coordinated without inflammation. Research suggests that, in symptomatic people with inflammatory bowel disease, fecal calprotectin is associated with endoscopically active disease 2. In other words, the number tends to move with what a camera would see on the inside of the bowel.
The practical way to read a high result is in three steps. The observation is that the stool contains more calprotectin than the laboratory's reference range allows. The inference is that neutrophils are entering the gut wall, which is suboptimal and deserves explanation rather than reassurance. The next step is a conversation with a clinician about the rest of the picture, because a single stool number is one input into a decision, never the decision itself.
Most laboratories report fecal calprotectin in micrograms per gram of stool and group results into a normal band, a borderline band and a clearly raised band. The thresholds below are the ones commonly used, not universal cut-offs.
| Result band (µg/g of stool) | How laboratories commonly regard it |
|---|---|
| Below about 50 | Within the typical reference range, significant neutrophil traffic into the gut is unlikely |
| About 50 to 200 | Borderline or grey zone, often repeated or read alongside symptoms and other tests |
| Above about 200 | Clearly raised, usually prompts further assessment by a clinician |
| Well above 200, for example several hundred and upward | Markedly raised, generally regarded as a stronger signal of active mucosal inflammation |
These are typical laboratory reference ranges, not diagnostic cut-offs, and they vary by lab, assay, age and sex. Children, older adults and people recovering from a gut infection can sit higher than a young healthy adult for reasons that have nothing to do with chronic disease. The threshold a laboratory prints on the report is the one that applies to that report, and comparing a value against a number found online can be misleading.
The cut-off chosen also changes what the test does. A lower threshold catches more people with genuine inflammation but flags more people without it, while a higher threshold does the reverse. Reviews of the marker in inflammatory bowel disease describe exactly this trade-off between thresholds and performance 4. That is why clinicians treat the printed cut-off as a starting point for interpretation rather than a verdict, and why the size of the number usually matters more than whether it crossed a line by a few units.
Because fecal calprotectin is measured by immunoassay, and different assays do not produce identical values from the same material. A comparison of three different fecal calprotectin immunoassays found that the results were not directly interchangeable between methods 5.
That has a direct practical consequence. If a first test was run by one laboratory and a follow-up by another, a change in the number may reflect the change of method rather than a change in the gut. Where a value is being tracked over time, using the same laboratory and the same assay keeps the comparison honest.
Sampling adds its own variation. Calprotectin is not evenly distributed through a stool, so where the sample is taken from the specimen affects the reading.
None of this makes the test unreliable. It means the number should be read as a signal with a margin around it, not as a precise measurement to two decimal places. A result of 180 and a result of 220 from different laboratories are closer to each other than the cut-off line between them suggests.
Anything that brings neutrophils into the bowel wall can raise fecal calprotectin, which includes a long list of causes beyond chronic inflammatory bowel conditions. Studies indicate that raised values are also found in gut infections, in colorectal neoplasia and in other processes that inflame the intestinal mucosa 3.
The usual categories worth knowing about are these. Infectious gastroenteritis, whether bacterial, viral or parasitic, can lift the number sharply and then let it fall over the following weeks as the lining recovers. Bleeding into the gut from any source adds inflammatory cells to stool. Conditions affecting the small bowel lining, including coeliac disease, can raise it. Polyps and tumours in the colon can raise it. Diverticular inflammation can raise it. Some commonly used medicines are recognised causes of gut lining irritation, which is one reason a clinician reviews everything you take, prescription or otherwise, before interpreting the result.
Age is a quiet confounder. Values tend to run higher at the extremes of age, so a number that looks mildly raised in an older adult may read differently to a clinician than the same number in a 30 year old.
The honest summary is that a raised value narrows the question from "is something going on in the gut" to "what is going on in the gut", and that second question needs more than a stool test. A result that is raised without an obvious explanation is worth discussing with a clinician rather than monitoring alone, because the value of the marker lies in what it prompts next.
It is one of the better tools for that job, which is the main reason it is ordered. Studies suggest that fecal calprotectin helps distinguish inflammatory bowel disease from functional bowel disorders such as irritable bowel syndrome, because functional conditions do not typically drive neutrophils into the intestinal lining 3.
The logic is mechanical rather than statistical. Irritable bowel syndrome involves altered gut motility, visceral sensitivity and gut to brain signalling, and it can be genuinely debilitating, but it does not produce the neutrophil influx that inflammatory bowel disease does. So the stool number stays low in the first group and tends to rise in the second. That difference is what makes the test useful for triage when symptoms overlap, and reviews of the marker position it as a tool for deciding who needs a colonoscopy and who probably does not 4.
Two cautions keep this honest. First, triage is not diagnosis. A high number does not name Crohn's disease or ulcerative colitis, and a low number does not confer a label of irritable bowel syndrome. Both remain clinical diagnoses that a clinician makes from the whole picture, usually including direct visualisation of the bowel.
Second, the two situations are not mutually exclusive. People living with an inflammatory bowel condition in remission can still have functional symptoms, and in that situation the stool number is often the thing that tells a clinician which problem is driving the current flare of symptoms. Used that way, the test answers a specific question rather than a general one.
A borderline result means the test has not settled the question, and it usually leads to a repeat sample rather than an immediate next investigation. Values in the band between the normal cut-off and the clearly raised band are common and are the weakest part of the test's performance.
Several ordinary things can land a person there. A recent gut infection that is still resolving, a sampling difference within the stool, day to day biological variation, or genuinely low grade inflammation that has not yet declared itself.
What a clinician weighs alongside a grey zone number is the symptom pattern. Blood in the stool, waking at night to open the bowels, unintentional weight loss, fever, a family history of inflammatory bowel disease or anaemia all push toward investigating sooner. A grey zone number in someone with longstanding, stable, non-alarming symptoms is read more cautiously, and often rechecked.
The mistake to avoid is treating the cut-off as a cliff edge. A value of 60 is not categorically different from a value of 45, and neither should be read in isolation. The useful question is not "am I over the line", it is "what does this number, plus my symptoms, plus my bloodwork, suggest about whether my bowel lining is inflamed". That question belongs to a clinician, and a borderline number is a reason to ask it rather than to stop asking.
A normal result makes significant neutrophil driven inflammation of the bowel lining less likely, which is genuinely reassuring when symptoms have raised the question of inflammatory bowel disease. In practice, that is the test's strongest use, ruling out rather than ruling in.
There are limits worth knowing. The sample reflects the stool that was collected, and a single low value cannot speak for every day or every segment of the gut. Disease confined to the upper small bowel can produce lower stool values than disease in the colon, so a normal number does not exclude everything in the gastrointestinal tract 3. Processes that do not recruit neutrophils, including many functional and motility problems, food intolerances and some causes of malabsorption, can leave the number entirely normal while symptoms persist.
A normal number also does not address causes outside the bowel wall. Biliary problems, pancreatic insufficiency and gynaecological causes of abdominal pain can all coexist with a perfectly normal stool marker.
So the correct reading of a normal result is narrow and useful rather than broad and reassuring. It says that one specific mechanism, neutrophils crossing into the intestinal lining in quantity, is unlikely to be driving the picture at the time the sample was taken. Ongoing symptoms with a normal value still deserve a clinician's attention, and the next step is usually to look elsewhere rather than to assume nothing is wrong. Never treat a normal stool marker as permission to stop investigating symptoms that are not improving.
C-Reactive Protein is a blood protein that rises with systemic inflammation from any source, so it complements a stool marker rather than duplicating it. A meta-analysis in symptomatic inflammatory bowel disease found that fecal calprotectin detected endoscopic activity more accurately than C-Reactive Protein did 2, which is why the stool test carries more weight for gut specific questions.
FitScript's optimal range for C-Reactive Protein is 0 to 1 mg/L, against a typical laboratory reference range of 0 to 3 mg/L. Optimal ranges are FitScript's optimization targets, not diagnostic cut-offs. The dedicated guide covers what the marker measures, how it is tested and how a result is interpreted in more detail.
It is a single stool sample, not a urine sample and not a blood test, collected at home into a small container supplied by the laboratory. Most kits include a collection device and a tube with a measuring spoon or a probe that picks up a fixed amount of stool, which is then sent back for analysis.
The practical points matter more than people expect. The sample should not be contaminated with urine or toilet water, both of which dilute the material. Because calprotectin is not distributed evenly through a stool, laboratories ask for the sample to be taken as instructed rather than from whichever part is easiest. Loose, watery stools can also read differently from formed ones, since the marker is reported per gram of stool and water content changes that denominator.
Timing and storage are usually specified on the kit. The protein's stability is one of its advantages, and research suggests it remains measurable in stool for several days at ambient temperature 1, but following the kit instructions on refrigeration and return time removes a variable from the result.
Two further habits help. Note on the request form anything relevant from the preceding weeks, including a recent gut infection or a course of medication, because that context changes how the number is read. And if a value is being tracked over time, keep using the same laboratory so the assay stays constant. None of this requires fasting or any preparation of diet, which makes the test easier than most.
For people already diagnosed, the test shifts from triage to monitoring, and it is used to judge whether the bowel lining is quiet or active without putting a camera in every time symptoms change. That is its most developed role.
The depth of remission can be graded. Research suggests that, in ulcerative colitis, a lower faecal calprotectin is associated with histologic remission, meaning healing visible under the microscope rather than just symptom control 6. That matters because symptoms and mucosal healing do not always move together. A person can feel well while the lining is still inflamed, and can feel unwell with a quiet lining.
The marker is also used to watch for relapse and to assess recurrence after bowel surgery, and reviews of the marker in inflammatory bowel disease describe both applications alongside its role in monitoring response to management 4. A number that climbs over sequential tests tends to prompt a closer look sooner than a number that stays flat.
What the test does not do is decide management. It describes the state of the bowel lining, and what follows from that description is a clinical decision made by the gastroenterologist or other licensed provider who knows the full history. The useful discipline for a member tracking this over time is consistency of laboratory, consistency of collection method and a record of the values in sequence, so that trend rather than a single reading drives the conversation.
A stool inflammation marker answers one question, so it is usually read beside blood tests that describe the consequences and the context of gut inflammation. The table below lists what each commonly added marker contributes.
| Marker | What it adds next to a raised stool result |
|---|---|
| C-Reactive Protein | A blood signal of systemic inflammation from any source, useful as a cross-check rather than a gut specific measure |
| ESR | A slower moving blood measure of inflammation that reflects changes over weeks rather than days |
| Hemoglobin | Shows whether oxygen carrying capacity has fallen, which raises questions about blood loss or poor absorption |
| Ferritin and iron studies | Describe iron stores and availability, which can shift with chronic gut inflammation or ongoing blood loss |
| Albumin | A protein that can fall when inflammation is sustained or when protein is lost through the gut |
| Platelet count and white cell count | Routine blood counts that often move with active inflammation |
| Coeliac serology | Tests for an immune reaction to gluten, one of the small bowel causes a clinician considers |
| Stool infection testing | Looks for bacterial, viral or parasitic causes of an inflamed bowel lining |
FitScript's membership covers 150+ biomarkers tested per year with interpretation by Atlas, FitScript's AI health advisor, which is how blood side inflammation and nutritional markers get tracked over time. A stool marker like this one sits outside a standard blood panel and is ordered by a clinician for a specific question. The point of grouping them is pattern recognition. Inflammation in the gut plus falling hemoglobin plus low ferritin tells a different story from inflammation in the gut with normal blood counts, and that pattern shapes the next step.
There is no single correct interval, because the right timing depends on why the test was ordered and what the clinician is trying to learn. Repeat timing is a clinical decision, and any fixed number of weeks quoted without knowing the situation would be guesswork.
The logic behind the decision is easier to describe. If the question is whether a borderline value was a blip, a repeat sample after enough time for a transient cause to settle makes sense. If the question is whether inflammation is responding to a change in management, the repeat is timed to when a change would plausibly show. If the question is surveillance in someone stable, testing is spaced out and tracked as a trend.
Three things make a repeat more informative. Use the same laboratory and assay, since values are not interchangeable between methods 5. Collect the sample the same way each time. And record symptoms alongside the number, because the pair together says more than either alone.
What a repeat test cannot do is replace the investigation a clearly raised value may warrant. Rechecking a markedly high number instead of looking into the cause delays the answer. The sensible division is that borderline values are often rechecked, and clearly raised values are investigated, with a clinician deciding which category a given result falls into.
Any clearly raised value is worth discussing with a clinician, and some situations are worth raising promptly rather than at the next routine appointment. A raised number combined with visible blood in the stool, black or tarry stools, unintentional weight loss, fever, persistent vomiting, severe or worsening abdominal pain, or waking at night to open the bowels falls into that group.
The same applies to a raised value alongside new anaemia, a markedly high number in someone who has never had gut symptoms investigated, or a number that climbs steadily across repeat tests. In people with an established inflammatory bowel condition, a rising value during a period of worsening symptoms is a reason to contact the treating team rather than wait.
What not to do is also worth stating. Do not ignore a raised result because you feel well, and do not assume a high number must be an inflammatory bowel condition. Both errors come from reading a single marker as if it were the whole picture.
This article is educational and is not medical advice. Discuss your results, and any treatment decision that follows from them, with a clinician or licensed provider who can see your full history, because a licensed provider evaluates what is appropriate for an individual and a stool number alone never settles that.
For the blood side of the same picture, the guides to esr and hemoglobin explain what those markers measure and how they are read alongside a gut inflammation result.
Many laboratories regard results under about 50 µg/g as within the reference range, 50 to 200 µg/g as borderline, and values above about 200 µg/g as clearly raised. These bands differ between laboratories and assays, so the threshold printed on your own report is the one that applies. A clinician interprets the number alongside your symptoms and other tests rather than against a figure found online.
No. A high result shows that white blood cells have moved into the gut lining, which indicates inflammation somewhere in the intestine, but it does not name a condition. Infections, bleeding, coeliac disease, polyps and other causes can all raise the number. Diagnosis requires a clinician, usually with further testing such as a direct look inside the bowel.
It is a stool test. A small sample of stool is collected at home into a container supplied by the laboratory, then returned for analysis. Urine and toilet water contaminate the sample and should be kept out of it. No fasting or dietary preparation is needed.
The test measures a protein released by white blood cells that enter the gut lining, so it reflects inflammation rather than stress itself. Stress can certainly worsen gut symptoms without changing this marker. That is part of why the test is useful when symptoms could come from either an inflamed bowel or a sensitive one. Interpretation still belongs to a clinician who knows your history.
A normal result makes significant inflammation of the bowel lining less likely, which is reassuring, but it is not an absolute exclusion. Disease confined to the upper small bowel can give lower stool values, and a single sample reflects only one day. Ongoing symptoms with a normal result still deserve a clinician's attention, usually by looking at other possible causes.
Different laboratories use different measurement methods, and values from one method are not directly interchangeable with another. The protein is also not spread evenly through a stool, and levels vary from day to day. If you are tracking this marker over time, use the same laboratory and follow the same collection instructions each time.
There is no fixed interval that fits everyone, because the right timing depends on why the test was ordered. Borderline values are often rechecked after enough time for a temporary cause to settle, while clearly raised values are usually investigated rather than simply repeated. Your clinician decides which applies and sets the timing.
Contact a clinician promptly if a raised result comes with blood in the stool, black or tarry stools, unintentional weight loss, fever, severe or worsening abdominal pain, or waking at night to open your bowels. The same applies if a value keeps climbing across repeat tests. Do not ignore a raised result simply because you feel well.